抑制剂-话题@MedSci

#抑制剂#

1990篇内容 | 3115人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1852863, encodeId=93f518528637a, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=免费回放：JAK抑制剂带来风湿免疫病的治疗范式转变, objectType=article, longId=293708, objectId=a9bd293e08d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9bd293e08d8, replyNumber=0, likeNumber=38, createdTime=2022-07-22, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9bd293e08d8, moduleTitle=免费回放：JAK抑制剂带来风湿免疫病的治疗范式转变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9bd293e08d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852977, encodeId=b06418529e713, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=为肺纤维化按下暂停键！新型PDE4B抑制剂显著延缓特发性肺纤维化（IPF）患者肺功能下降, objectType=article, longId=727875, objectId=378ce27875c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=378ce27875c7, replyNumber=0, likeNumber=116, createdTime=2023-03-14, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=378ce27875c7, moduleTitle=为肺纤维化按下暂停键！新型PDE4B抑制剂显著延缓特发性肺纤维化（IPF）患者肺功能下降, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=378ce27875c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852852, encodeId=4b81185285287, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Clin Cancer Res：首次人源性I期研究评估了PI3K/mTOR抑制剂GDC-0084在胶质瘤患者中的应用, objectType=article, longId=293008, objectId=928829300830, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=928829300830, replyNumber=0, likeNumber=54, createdTime=2022-02-18, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=928829300830, moduleTitle=Clin Cancer Res：首次人源性I期研究评估了PI3K/mTOR抑制剂GDC-0084在胶质瘤患者中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=928829300830)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1853046, encodeId=1e051853046fb, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=磺脲类药物治疗2型糖尿病时若需添加SGLT-2抑制剂，可适当减少剂量以降低“低血糖”风险, objectType=article, longId=737027, objectId=7b6ee370276e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b6ee370276e, replyNumber=0, likeNumber=68, createdTime=2023-06-16, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b6ee370276e, moduleTitle=磺脲类药物治疗2型糖尿病时若需添加SGLT-2抑制剂，可适当减少剂量以降低“低血糖”风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b6ee370276e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852949, encodeId=44241852949dd, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=JCEM：长期使用质子泵抑制剂与2型糖尿病风险的关系, objectType=article, longId=724462, objectId=2ffae244625c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ffae244625c, replyNumber=0, likeNumber=132, createdTime=2022-12-11, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ffae244625c, moduleTitle=JCEM：长期使用质子泵抑制剂与2型糖尿病风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ffae244625c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852906, encodeId=6e6d185290653, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Diabetes Care：免疫检查点抑制剂与1型糖尿病风险, objectType=article, longId=300377, objectId=6ed53003e7f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ed53003e7f1, replyNumber=0, likeNumber=80, createdTime=2023-01-07, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ed53003e7f1, moduleTitle=Diabetes Care：免疫检查点抑制剂与1型糖尿病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ed53003e7f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852888, encodeId=a0fb18528889b, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Acta Haematol：血清铁蛋白的阈值可区分低氧诱导因子脯氨酰羟化酶结构域抑制剂治疗期间血小板增加风险较高的患者, objectType=article, longId=298962, objectId=ad5729896288, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad5729896288, replyNumber=0, likeNumber=78, createdTime=2023-01-16, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad5729896288, moduleTitle=Acta Haematol：血清铁蛋白的阈值可区分低氧诱导因子脯氨酰羟化酶结构域抑制剂治疗期间血小板增加风险较高的患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad5729896288)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852971, encodeId=23f318529e196, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Cardiovasc Diabetol：不同SGLT2抑制剂对糖尿病患者心血管不良结局风险的影响, objectType=article, longId=727305, objectId=fc4be2730555, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc4be2730555, replyNumber=0, likeNumber=92, createdTime=2023-01-24, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc4be2730555, moduleTitle=Cardiovasc Diabetol：不同SGLT2抑制剂对糖尿病患者心血管不良结局风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc4be2730555)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1853011, encodeId=1de618530115e, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=全球首创EZH2抑制剂他泽司他完成中国首例患者用药, objectType=article, longId=730964, objectId=d910e309647f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d910e309647f, replyNumber=0, likeNumber=69, createdTime=2022-08-10, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d910e309647f, moduleTitle=全球首创EZH2抑制剂他泽司他完成中国首例患者用药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d910e309647f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1853029, encodeId=97ea18530295c, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=中国之声：首个国产PD-1抑制剂联合双铂化疗新辅助治疗IIB-IIIB期NSCLC安全有效！| WCLC 2022速递, objectType=article, longId=735667, objectId=7b4ee35667af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b4ee35667af, replyNumber=0, likeNumber=127, createdTime=2022-11-23, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b4ee35667af, moduleTitle=中国之声：首个国产PD-1抑制剂联合双铂化疗新辅助治疗IIB-IIIB期NSCLC安全有效！| WCLC 2022速递, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b4ee35667af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852864, encodeId=b0aa1852864df, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=JAMA Netw Open：钠-葡萄糖共转运蛋白2抑制剂与2型糖尿病患者心血管转归和其他心血管疾病危险因素的相关性, objectType=article, longId=293599, objectId=6fd12935999c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fd12935999c, replyNumber=0, likeNumber=79, createdTime=2022-03-06, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fd12935999c, moduleTitle=JAMA Netw Open：钠-葡萄糖共转运蛋白2抑制剂与2型糖尿病患者心血管转归和其他心血管疾病危险因素的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6fd12935999c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1853022, encodeId=12cc1853022f9, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Lancet Oncol：氟维司群联合Capivasertib治疗芳香化酶抑制剂耐药性晚期/复发性ER+HER2-乳腺癌, objectType=article, longId=729208, objectId=e8d9e29208b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8d9e29208b5, replyNumber=0, likeNumber=79, createdTime=2022-07-06, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8d9e29208b5, moduleTitle=Lancet Oncol：氟维司群联合Capivasertib治疗芳香化酶抑制剂耐药性晚期/复发性ER+HER2-乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8d9e29208b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852917, encodeId=06d3185291e02, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=JAMA Netw Open：胰高升糖素样肽-1受体激动剂与二肽基肽酶-4抑制剂的使用与2型糖尿病和晚期慢性肾脏疾病患者死亡率的关系, objectType=article, longId=301330, objectId=e46e30133002, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e46e30133002, replyNumber=0, likeNumber=98, createdTime=2022-12-15, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e46e30133002, moduleTitle=JAMA Netw Open：胰高升糖素样肽-1受体激动剂与二肽基肽酶-4抑制剂的使用与2型糖尿病和晚期慢性肾脏疾病患者死亡率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e46e30133002)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1853018, encodeId=8d0018530180f, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Circulation：SGLT2和血管紧张素转换酶抑制剂联合治疗对肾脏和血管的影响, objectType=article, longId=732271, objectId=8eb7e3227136, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8eb7e3227136, replyNumber=0, likeNumber=79, createdTime=2023-01-30, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8eb7e3227136, moduleTitle=Circulation：SGLT2和血管紧张素转换酶抑制剂联合治疗对肾脏和血管的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8eb7e3227136)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852862, encodeId=aad2185286242, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=JAMA Neurology： COMT抑制剂对帕金森左旋多巴疗法辅助效果不佳, objectType=article, longId=293644, objectId=f14d293644c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f14d293644c9, replyNumber=0, likeNumber=83, createdTime=2022-09-09, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f14d293644c9, moduleTitle=JAMA Neurology： COMT抑制剂对帕金森左旋多巴疗法辅助效果不佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f14d293644c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852874, encodeId=a22f18528e4e4, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=UCB正在寻求IL-17A 和 IL-17F 双重抑制剂Bimzelx在银屑病关节炎中的批准, objectType=article, longId=294569, objectId=656829456957, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=656829456957, replyNumber=0, likeNumber=64, createdTime=2022-09-19, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=656829456957, moduleTitle=UCB正在寻求IL-17A 和 IL-17F 双重抑制剂Bimzelx在银屑病关节炎中的批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=656829456957)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852891, encodeId=59bd18528916f, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Ann Rheum Dis：JIA儿童接受TNF抑制剂治疗会增加银屑病发病率, objectType=article, longId=299223, objectId=6907299223aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6907299223aa, replyNumber=0, likeNumber=100, createdTime=2022-06-08, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6907299223aa, moduleTitle=Ann Rheum Dis：JIA儿童接受TNF抑制剂治疗会增加银屑病发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6907299223aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852960, encodeId=ca491852960f9, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=ARD：幼年特发性关节炎儿童使用TNF抑制剂会增加银屑病发病率, objectType=article, longId=726060, objectId=5aa2e26060a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5aa2e26060a3, replyNumber=0, likeNumber=82, createdTime=2023-03-19, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5aa2e26060a3, moduleTitle=ARD：幼年特发性关节炎儿童使用TNF抑制剂会增加银屑病发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5aa2e26060a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852880, encodeId=a8801852880f8, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Lancet Oncol：芳香酶抑制剂对比他莫昔芬治疗绝经前的ER阳性早期乳腺癌, objectType=article, longId=295172, objectId=0c822951e291, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c822951e291, replyNumber=0, likeNumber=58, createdTime=2022-12-05, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c822951e291, moduleTitle=Lancet Oncol：芳香酶抑制剂对比他莫昔芬治疗绝经前的ER阳性早期乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c822951e291)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1853052, encodeId=886b1853052be, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle= Leuk Res：用溴结构域抑制剂 PLX51107 和阿扎胞苷治疗皮肤白血病患者的主要临床反应, objectType=article, longId=739092, objectId=578de3909292, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=578de3909292, replyNumber=0, likeNumber=104, createdTime=2022-12-17, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=578de3909292, moduleTitle= Leuk Res：用溴结构域抑制剂 PLX51107 和阿扎胞苷治疗皮肤白血病患者的主要临床反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=578de3909292)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抑制剂

2020-05-29

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

免费回放：JAK抑制剂带来风湿免疫病的治疗范式转变

2022-07-22

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

为肺纤维化按下暂停键！新型PDE4B抑制剂显著延缓特发性肺纤维化（IPF）患者肺功能下降

2023-03-14

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Clin Cancer Res：首次人源性I期研究评估了PI3K/mTOR抑制剂GDC-0084在胶质瘤患者中的应用

2022-02-18

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

磺脲类药物治疗2型糖尿病时若需添加SGLT-2抑制剂，可适当减少剂量以降低“低血糖”风险

2023-06-16

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

JCEM：长期使用质子泵抑制剂与2型糖尿病风险的关系

2022-12-11

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Diabetes Care：免疫检查点抑制剂与1型糖尿病风险

2023-01-07

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Acta Haematol：血清铁蛋白的阈值可区分低氧诱导因子脯氨酰羟化酶结构域抑制剂治疗期间血小板增加风险较高的患者

2023-01-16

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Cardiovasc Diabetol：不同SGLT2抑制剂对糖尿病患者心血管不良结局风险的影响

2023-01-24

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

全球首创EZH2抑制剂他泽司他完成中国首例患者用药

2022-08-10

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

中国之声：首个国产PD-1抑制剂联合双铂化疗新辅助治疗IIB-IIIB期NSCLC安全有效！| WCLC 2022速递

2022-11-23

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

JAMA Netw Open：钠-葡萄糖共转运蛋白2抑制剂与2型糖尿病患者心血管转归和其他心血管疾病危险因素的相关性

2022-03-06

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Lancet Oncol：氟维司群联合Capivasertib治疗芳香化酶抑制剂耐药性晚期/复发性ER+HER2-乳腺癌

2022-07-06

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

JAMA Netw Open：胰高升糖素样肽-1受体激动剂与二肽基肽酶-4抑制剂的使用与2型糖尿病和晚期慢性肾脏疾病患者死亡率的关系

2022-12-15

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Circulation：SGLT2和血管紧张素转换酶抑制剂联合治疗对肾脏和血管的影响

2023-01-30

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

JAMA Neurology： COMT抑制剂对帕金森左旋多巴疗法辅助效果不佳

2022-09-09

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

UCB正在寻求IL-17A 和 IL-17F 双重抑制剂Bimzelx在银屑病关节炎中的批准

2022-09-19

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Ann Rheum Dis：JIA儿童接受TNF抑制剂治疗会增加银屑病发病率

2022-06-08

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

ARD：幼年特发性关节炎儿童使用TNF抑制剂会增加银屑病发病率

2023-03-19

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Lancet Oncol：芳香酶抑制剂对比他莫昔芬治疗绝经前的ER阳性早期乳腺癌

2022-12-05

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Leuk Res：用溴结构域抑制剂 PLX51107 和阿扎胞苷治疗皮肤白血病患者的主要临床反应

2022-12-17

科室
- - 订阅+
  - 更多科室
工具
服务